University of the Sciences in Philadelphia

University of the Science in Philadelphia will host the the partners of the University City KIZ in an informative session to learn more about tech transfer best practices. The program will be held on Wednesday May 14 from 4 to 7:30 p.m. in the McNeil STC (43rd St. and Woodland Ave.). Dinner and networking begin at 6 p.m.

Who Should Attend? University research faculty, Entrepreneurs, and UC KIZ community partners.

While this is a free event, registration is required. Please call 267-295-3295 for more information.

Agenda:
4:00 Philip P. Gerbino, PharmD (USP), Historical Perspective and Status Report of UC KIZ

4:15 Robert McGrath, PhD (Drexel University), The Technology Transfer Process in Academia

4:35 Barbara Schilberg, JD, Esq. (BioAdvance), From Research Labs to Start-Ups and Established Companies

4:55 Stephen S. Tang, PhD (Science Center), The Role of the Science Center in Supporting Entrepreneurship

5:15 Katherine Chou, MS, MBA (Thomas Jefferson University) and Shanaz Tejani-Butt, PhD (USP), The Buddy-Mentor KIZ Model between TJU and USP

5:35 Questions / Discussion

6:00 Gary Sayed, PhD (USP), Faculty Awards

6:30 Dinner and Networking (STC’s Atrium)

Speaker Information
Katherine Chou, MS, MBA
Katherine Chou, MS, MBA is the Executive Director of Thomas Jefferson University’s Office of Technology Transfer and Business Development. She is responsible for managing Jefferson’s intellectual property, including patent protection and
commercialization. She advises the development of business plans and helps create start-ups, and negotiates and reviews license, research and clinical trial agreements and for cultivating research collaboration opportunities for Jefferson’s faculty with corporate partners.

Philip P. Gerbino, Pharm D
Philip P. Gerbino, PharmD, is President of University of the Sciences in Philadelphia where he has worked for more than 30 years as an educator and administrator.
Dr. Gerbino is a Fellow of the College of Physicians of Philadelphia, the American Pharmaceutical Association, Academy of Pharmacy Practice and Management and the American Society of Consultant Pharmacists. He was the 2006 recipient of the Phi Lambda Sigma-Procter & Gamble National Leadership Award and retains the title of “Linwood F. Tice Professor” at PCP.

Robert McGrath, PhD
Dr. Robert McGrath is the Associate Vice Provost and Executive Director of
Entrepreneurship and Technology Commercialization at Drexel University. He and his team are responsible for managing and commercializing the intellectual property assets of the University. Dr. McGrath has negotiated dozens of license agreements and sponsored research agreements to commercialize and fund university technologies. Dr. McGrath has organized the Basic Licensing Course for the Association
of University Technology Managers, and currently serves as an advisor for Ben Franklin Technology Partners.

M. Gary Sayed, PhD
M. Gary Sayed, PhD, is the Provost and Senior Vice President for Academic Affairs
at USP. Prior to joining the university in 2007, Dr. Sayed was Dean of the Charles
R. Drew University of Medicine and Science College of Science and Health. Trained as a nuclear medicine scientist, Dr. Sayed has been active in the education of health professions students, medical residents and fellows, as well as graduate students
and technologists.

Barbara Schilberg, JD, Esq.
Ms. Schilberg has over 20 years experience in the life sciences. Under her leadership, BioAdvance has invested $11.5 million in 21 seed-stage companies and nine projects in areas such as Alzheimer’s Disease, cancer, diabetes, obesity and infectious diseases. The portfolio companies have raised over $215 million in subsequent funding and five have been sold. Ms. Schilberg’s industry experience includes senior management positions at Cephalon, Incara Pharmaceuticals, Advanced Medicine (now Theravance) and Locus Discovery, Inc. Previously, Ms. Schilberg represented biopharmaceutical companies and universities as a partner with Morgan, Lewis & Bockius. She received a J.D. from the University of Virginia.

Stephen Tang, PhD
Dr. Tang, President & CEO of the Science Center is a seasoned life science, energy technology, and management consulting executive. He previously was group vice president and general manager with Olympus America Inc., where he led the U.S. operations for the company's $1 billion global Life Science businesses. Before joining Olympus in 2005, he was president and CEO of Millennium Cell Inc. (NASDAQ: MCEL), an Eatontown, NJ-based energy technology firm that he led through its
initial public offering in 2000.

Shanaz Tejani-Butt, PhD.
Shanaz Tejani-Butt, PhD, is a Professor of Pharmacology and Toxicology in USP's Department of Pharmaceutical Sciences and Associate Dean for the College of Graduate Studies. Her research focuses on the use of animal models to study the neurobiological mechanisms underlying the onset and treatment of depressive illness and addiction. She is the author of numerous peer-reviewed publications and research presentations. In 2003, she was appointed as USP’s first Administrative Fellow and became involved in a number of projects, one of which was to develop an implementation plan to enhance technology transfer at USP.

University City Keystone Innovation Zone Partners
Bio Advance
Commerce Bank
Drexel University
Science Center
Thomas Jefferson University
University of Pennsylvania
University of the Science in Philadelphia
The Wistar Institute